Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
Article in Frontiers in Pharmacology (September 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Perturbed collagen metabolism underlies lymphatic recanalization failure in Gata2 heterozygous deficient mice
Article in The Journal of Biochemistry (January 2024)
The Future of Lymphedema: Potential Therapeutic Targets for Treatment
Article in Current Breast Cancer Reports (June 2023)